Yuichi Yamasaki
7PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 19, 2025
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial.Hermine I Brunner, Jordi Antón, Inmaculada Calvo-Penadés
|Jul 22, 2025
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin-Associated Periodic Syndrome.Kentaro Kato, Yoshitaka Honda, Takashi Kamatani
|Jan 25, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide Survey.Takayuki Miyamoto, Kazushi Izawa, Sho Masui
|Oct 05, 2022
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis.Yuichi Yamasaki, Aki Nakamura, Tomohiro Kubota
|Feb 12, 2021
Clinical impact of myositis-specific autoantibodies on long-term prognosis of juvenile idiopathic inflammatory myopathies: multicentre study.Yuichi Yamasaki, Norimoto Kobayashi, Shinji Akioka
|Jul 06, 2020
A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease.Yuichi Yamasaki, Tomohiro Kubota, Syuji Takei
Pageof 2
Frequent Collaborators
2 joint publications
Ryuta Nishikomori
2 joint publications
Yoshitaka Honda
2 joint publications
Masaki Shimizu
2 joint publications
Kazushi Izawa
1 joint publications
Syuji Takei
1 joint publications
Hiroyuki Imanaka
1 joint publications
Andre van Maurik
1 joint publications
Yoshifumi Kawano
1 joint publications
Shinji Akioka
1 joint publications
Shunichiro Takezaki
